About BC Platforms
BC Platforms is a company based in Zurich (Switzerland) founded in 1997. BC Platforms has raised $47.15 million across 7 funding rounds from investors including IQVIA, Debiopharm and European Union. The company has 8 employees as of December 31, 2024. BC Platforms has completed 1 acquisition, including 4Pharma. BC Platforms offers products and services including Global Data Network, Data Platform & Analytics, Scientific Services, and Trusted Research Environments. BC Platforms operates in a competitive market with competitors including DNAnexus, Genomics, Seven Bridges Genomics, Depixus and Ingenuity Systems, among others.
- Headquarter Zurich, Switzerland
- Employees 8 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BC Platforms
BC Platforms offers a comprehensive portfolio of products and services, including Global Data Network, Data Platform & Analytics, Scientific Services, and Trusted Research Environments.
Facilitates access to real-world data for global research and collaboration.
Enables data management and interoperability for secure research environments.
Provides analytics for clinical trials and real-world data studies.
Supports secure collaboration and AI model training in healthcare.
People of BC Platforms
Unlock access to complete
Unlock access to complete
Funding Insights of BC Platforms
BC Platforms has successfully raised a total of $47.15M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $318.22 thousand completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BC Platforms
BC Platforms has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include IQVIA, Debiopharm and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on buyouts of tech-driven companies
|
Locked | Locked | Locked | |
|
Private equity investment firm
|
Locked | Locked | Locked | |
|
US-focused private equity and venture capital investments are managed.
|
Locked | Locked | Locked |
Investor details for BC Platforms
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BC Platforms
BC Platforms has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include 4Pharma.
Investment portfolio details for BC Platforms
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical trials are conducted by 4Pharma as a full-service CRO.
|
Locked | Locked | 2002 | Locked |
Complete acquisition details for BC Platforms
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - BC Platforms
Detailed financials for BC Platforms
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bc Platforms Comparisons
Peer comparison for BC Platforms
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BC Platforms
BC Platforms operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Genomics, Seven Bridges Genomics, Depixus and Ingenuity Systems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based genome informatics and data management are provided.
|
|
| Locked | Locked | Locked |
Genomic risk assessment and prevention platform is provided.
|
|
| Locked | Locked | Locked |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| Locked | Locked | Locked |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed and interpreted via web-based applications.
|
|
| Locked | Locked | Locked |
Developer of cloud-based software solutions for genomic analysis
|
Detailed competitors of BC Platforms
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bc Platforms
Complete news archive for BC Platforms
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BC Platforms
BC Platforms was founded in 1997 and raised its 1st funding round 19 years after it was founded.
BC Platforms is headquartered in Zurich, Switzerland.
BC Platforms is a funded company, having raised a total of $47.15M across 7 funding rounds to date.
As of Dec 31, 2024, the latest employee count at BC Platforms is 8.
BC Platforms was founded in 1997 in Zurich, Switzerland, and operates in the genomics and biotechnology sector. Software based on gene sequencing is developed for applications in agriculture, bio-banks, clinics, and biopharma research. A genomic data management platform is offered, through which data integration, secure analysis, and interpretation of molecular and clinical information are enabled. Operations focus on supporting research and clinical workflows across these domains.
BC Platforms's top competitors include DNAnexus, Eagle Genomics and Depixus.
BC Platforms offers Global Data Network, Data Platform & Analytics, Scientific Services, and Trusted Research Environments.
BC Platforms has made 1 acquisition, including 4Pharma.
BC Platforms has 6 investors. Key investors include IQVIA, Debiopharm, European Union, Jolt Capital, and Tesi.